BRNS (STOCKS)
Barinthus Biotherapeutics plc American Depositary Shares
$0.680000
+0.009000 (+1.34%)
Prev close: $0.671000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William Enright
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $27.82M
- Employees
- 105
- P/E (TTM)
- -0.52
- P/B (TTM)
- 0.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.14 | $-0.29 | +0.1456 | +50.98% |
|
Dec 2025 (Q4)
|
$-0.27 | $-0.35 | +0.0819 | +23.27% |
|
Sep 2025 (Q3)
|
$-0.24 | $-0.40 | +0.1629 | +40.43% |
|
Jun 2025 (Q2)
|
$-0.52 | $-0.34 | -0.1834 | -54.49% |
Financial Statements
| Revenues | $506.00K |
| Benefits Costs and Expenses | $67.14M |
| Costs And Expenses | $71.06M |
| Nonoperating Income/Loss | $3.92M |
| Operating Expenses | $71.06M |
| Research and Development | $25.56M |
| Other Operating Expenses | $45.50M |
| Operating Income/Loss | -$70.56M |
| Other Operating Income/Expenses | $506.00K |
| Income/Loss From Continuing Operations After Tax | -$66.46M |
| Income/Loss From Continuing Operations Before Tax | -$66.63M |
| Income Tax Expense/Benefit | -$175.00K |
| Income Tax Expense/Benefit, Deferred | -$175.00K |
| Net Income/Loss | -$66.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$30.00K |
| Net Income/Loss Attributable To Parent | -$66.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$66.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.64 |
| Diluted Earnings Per Share | -$1.64 |
| Basic Average Shares | 40,527,218 |
| Diluted Average Shares | 40,527,218 |
| Assets | $98.17M |
| Current Assets | $77.79M |
| Prepaid Expenses | $4.52M |
| Other Current Assets | $73.27M |
| Noncurrent Assets | $20.38M |
| Fixed Assets | $3.52M |
| Intangible Assets | $14.29M |
| Other Non-current Assets | $2.57M |
| Liabilities | $23.88M |
| Current Liabilities | $10.02M |
| Accounts Payable | $350.00K |
| Other Current Liabilities | $9.67M |
| Noncurrent Liabilities | $13.86M |
| Equity | $74.29M |
| Equity Attributable To Noncontrolling Interest | $84.00K |
| Equity Attributable To Parent | $74.21M |
| Liabilities And Equity | $98.17M |
| Net Cash Flow From Operating Activities | -$47.98M |
| Net Cash Flow From Operating Activities, Continuing | -$47.98M |
| Net Cash Flow From Investing Activities | $416.00K |
| Net Cash Flow From Investing Activities, Continuing | $416.00K |
| Net Cash Flow From Financing Activities | $2.00K |
| Net Cash Flow From Financing Activities, Continuing | $2.00K |
| Net Cash Flow | -$47.56M |
| Net Cash Flow, Continuing | -$47.56M |
| Comprehensive Income/Loss | -$56.31M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$22.00K |
| Comprehensive Income/Loss Attributable To Parent | -$56.29M |
| Other Comprehensive Income/Loss | $10.15M |